The effects of angiogenic growth factors on extravillous trophoblast invasion and motility

Placenta

Volumn 20, Issue 8, 1999, Pages 661-667

  Lash, G E ^a   Cartwright, J E ^b   Whitley, G St J ^c   Trew, A J ^c   Baker, P N ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR; HEPARIN; MESSENGER RNA; VASCULOTROPIN;

ARTERY; ARTICLE; CELL COUNT; CELL INVASION; CELL LINE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DECIDUA; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PLACENTA VILLUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST;

EID: 0032831620     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0427     Document Type: Article

References (33)

1. Ahmed A, Dunk C, Kniss D, Wilkes M. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest. 76:1997;779-791.
2. Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta. 19:1998;465-473.
3. Athanassiades A, Hamilton GS, Lala PK. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod. 59:1998;643-654.
4. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 4:1998;377-386.
5. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Nat Cancer Inst. 87:1995;506-516.
6. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynecol. 77:1977;573-593.
7. Brosens I, Robertson WB, Dixon HG. The physiological response to the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol. 93:1967;569-579.
8. Cartwright JE, Holden DP, Whitley GStJ. Hepatocyte growth factor regulates human trophoblast motility and invasion in a nitric oxide dependent manner. Br J Pharmacol. 1999.
9. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N, Smith S. Vascular endothelial growth factor receptor localisation and activation in human trophoblast and choriocarcinoma cells. Biol Reprod. 51:1994;524-530.
10. Choy MY, Manyonda IT. The phagocytic activity of human first trimester extravillous trophoblast. Hum Reprod. 13:1998;2941-2949.
11. Clark DE, Smith SK, Licence D, Charnock-Jones DS. Production of vascular endothelial growth factor antagonist by human trophoblast. Placenta. 18:1997;A17.
12. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 103:1996;1191-1196.
13. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol Rev. 13:1992;18-32.
14. Genbacev O, DeMesy Jensen K, Schubach Powin S, Miller RK. In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT cells). Placenta. 14:1993;463-475.
15. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
16. Lala PK, Hamilton GS, Athanassiades A. Trophoblast growth factors and signals. Trophobl Res. 12:1998;327-339.
17. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
18. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 113:1991;437-449.
19. Lunell NO, Lewander R, Mamoun I, Nylund L, Sarby S, Thornstrom S. Uteroplacental blood flow in pregnancy induced hypertension. Scand J Clin Lab Invest. 44:1984;28-35.
20. Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AJ. Homologs of a vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol. 68:1994;84-92.
21. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 88:1991;9267-9271.
22. Meekins JW, Pijenborg R, Hanssens M, McFadyen IR, VanAsshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 101:1994;669-674.
23. Paavonen K, Horelli-Kuitunen N, Chilov D, Kukk E, Pennanen S, Kallioniemi OP, Pajusola K, Olofsson B, Eriksson U, Joukov V, Palotie A, Alitalo K. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation. 93:1996;1079-1082.
24. Robertson WB, Brosens I, Dixon HG. Uteroplacenta vascular pathology. Eur J Obstet Gynecol Reprod Biol. 5:1975;47-65.
25. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt closely related to the fms family). Oncogene. 5:1990;519-524.
26. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 187:1992;1579-1586.
27. Trew AJ, Lash GE, Baker PN. An in vitro model of trophoblast invasion. Early Pregn. 1999.
28. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res. 83:1998;832-840.
29. Wheeler T, Elcock C, Anthony FW. Angiogenesis and the placental environment. Placenta. 16:1995;289-296.
30. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmaki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 56:1997;489-494.
31. Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood. 93:1999;1969-1979.
32. Yamada Y, Nezu J, Shimane M, Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 42:1997;483-488.
33. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger HJ, Viglietto G, Persico MG. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest. 76:1997;517-531.